Roche Obesity Pill Study
Obesity Pill Race Heats Up as Novo, Roche and Terns Share Data
The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, but the comparisons are rife with confounding variables, leaving analysts unsure about where to place their bets.
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
Roche shares drop on side effects result in early-stage obesity pill trial
Shares in Roche fell on Thursday after an early-stage obesity pill candidate that carries high market hopes was linked to a high rate of temporary side effects in its initial test phase on humans. Roche shares were down 4% at the open at 0700 GMT after the company presented late on Wednesday details on the trial.
Roche Says Obesity Pill’s Side Effects Blunted by Gradual Dosing
Roche Holding AG said side effects in a highly anticipated study of its experimental obesity pill were milder when it eased patients into higher doses more slowly, seeking to reassure investors that it can compete in the next generation of weight loss drugs.
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.
Roche shares knocked by concern over side effects in obesity pill trial
FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an elevated rate of temporary side effects in its initial test phase on humans.
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects
Roche’s stock fell after new data from an early-stage clinical trial of its closely watched oral weight-loss drug candidate prompted analysts to question the company’s potential to quickly enter a booming obesity market.
Roche Obesity Pill Study: What Are the Side Effects?
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Roche's Manu Chakravarthy talks weight loss drug trial results
Manu Chakravarthy, Roche, joins 'Fast Money' to talk its weight loss drug trial results. Snap poll after debate reveals state of presidential race between Trump and Harris Save Money On Steak With This Easy Costco Shopping Tip If you always use these 6 phrases,
Roche shares slip on obesity drug trial side effects
Shares of Roche (SIX:RO) fell on Thursday following reports from an early-stage trial of an obesity medication, which showed a high rate of temporary side effects. At 4:44 am (0844 GMT), Roche was trading 4% lower at
Roche Holding AG: A Cautious Hold Amidst Competition and Pipeline Uncertainties
Stifel Nicolaus analyst Eric Le Berrigaud has maintained their neutral stance on RHHVF stock, giving a Hold rating today. Eric Le ...
ENDPOINTS NEWS2d
Roche out­lines com­mer­cial man­u­fac­tur­ing strat­e­gy for GLP-1/GIP as­sets
Roche has already budgeted for future commercial manufacturing builds and established a network of contract manufacturers as ...
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...
Roche Holding AG (RHHVF) Receives a Hold from UBS
In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price ...
STAT5d
FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
FierceBiotech7d
Roche ramps up R&D with $1.4B Swiss facility
Roche’s R&D is moving on up. The pharma giant has opened two new high-rises in Basel, Switzerland, according to a Sept. 10 ...
Lunit announces partnership with Roche to integrate AI into PD-L1 biomarker testing
"Lunit announces partnership with Roche to integrate AI into PD-L1 biomarker testing" was originally created and published by ...
Gardaí to conduct fresh searches in Co Kilkenny for missing man Dean Roche
Father-of-one last seen almost 10 years ago after telling his mother he was going to purchase a car which was later found ...